Event recordings

Our second season of The Risk of Living Longer Series continued with the theme of prevention with a session focused on modelling gero-therapeutic interventions. We were joined by guest speakers from Crystallise Ltd who introduced their framework for understanding the impact of advances in gero-science. We addressed these key questions: what is gero-science and what are gero-therapeutics; how could we go about modelling the impact of gero-therapeutics; what is Crystallise’s framework for modelling the impact of advances in gero-science; how can practitioners use the outputs of this framework in practice.

After stellar engagement with our first series in Spring 2024, we are back by popular demand! It is our pleasure to announce the second season of our Risk of Living Longer webinars. Replay "Longevity science – advancing from cure to prevention" where we addressed these key questions: What is longevity science? Is prevention really better than a cure? What is preventative medicine (and why are we calling it medicine 3.0)? Should healthcare systems be spending more on prevention rather than cure? And how can this be encouraged? How can we encourage wider buy-in in society?

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Replay our last session of the series: Using Big Data and AI to Improve and Advance Longevity, to gain insights on the range of longevity-related AI use-cases: preventative medicine, accelerating drug discovery, establishing new genetic connections, and improving operational efficiency in health delivery. We also explored how the pace of change in longevity will be affected by AI developments, and which age groups are most likely to be affected.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session four of the series: Biological Clocks, to gain insights on how we can accelerate the feedback loop of medical interventions. We explored biomarkers: what they are, how accurate they are, and how they will develop. We also discussed implications from a life and health insurance perspective.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Replay session three of the series: Cancer Research, to gain insights on the most exciting areas of cancer research, how close these areas could be to breakthrough, and how might such breakthroughs impact life insurance books.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session two of the series: The biology of aging, to gain insights on how we should think in terms of the aging process, if we could ever cure aging, and what we could achieve along the way.

Our "Risk of Living Longer" webinar series focused on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session one of the series: An introduction to the question, gain insights on key areas of research to monitor for potential breakthroughs in longevity, what should we follow to understand the risk of living longer, and how could these considerations filter through into actuarial modeling and risk management.